This is the logo of the provider
EASD 2025 15 - 19 September 2025

Effect of semaglutide on the initiation of additional glucose-lowering therapy: An analysis of the SELECT trial

Authors :

Steven E Kahn1; Ole Kleist Jeppesen2; A Michael Lincoff3; Ildiko Lingvay4; Jorge Plutzky5; Anders Rasmussen Rinnov2; Donna H Ryan6; Scott S Emerson7

Affiliations
View Details Hide Details
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Keywords
Cardiovascular Disease
Congress short oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)